Can you imagine wound healing happening four times faster?

TENGO Therapeutics is a R&D focused medtech startup located on the research campus Garching, one of the largest scientific research centers in Europe, and develops innovative solutions based on nanotechnologies for a range of potential therapeutic applications.

TENGO Therapeutics is currently in preclinical development of its proprietary FibroActive technology for supported fibroblast migration that promises substantial acceleration of natural wound healing processes and has already identified first clinical research partners for the next development stages and clinical studies.

For the prospective commercialization of FibroActive, aiming at markets of approximately 50 million patients worldwide annually, TENGO Therapeutics intends to identify further potential industrial partners across various geographies and medical segments.

info@tengotherapeutics.com